Piribo: The mysteries of Chinese medicine continues for the western world, at least in terms of registration processes.

May 15, 2006 (PRLEAP.COM) Business News
Traditional Oriental medicines, especially traditional Chinese medicines have always been regarded by the occidental world as mysterious. Until recently not only could the chemical composition of traditional Chinese medicines not be expressed by a precise chemical structural formula, but also the indications of the majority of traditional Chinese medicines still can not be clearly described by the modern medical terminologies. How did the Chinese pharmaceutical authorities choose to administer the registration applications for such these traditional Chinese medicines?

This report, the third guidebook of the ‘China Pharmaceutical Guidebook Series’, will provide a detailed introduction to the Chinese pharmaceutical authorities' requirements for materials and clinical trials for application and approval of imported traditional Chinese medicine. The Chinese pharmaceutical authorities combined the traditional Chinese medicines and natural medicines into a category for registration application. Therefore, this guidebook will provide an introduction for registration application for both imported traditional Chinese medicines and natural medicines.

“Material and Clinical Trial requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medicines” is priced at £410 and is available in PDF format from Piribo. For more information, go to: http://www.piribo.com/search/results.html?k=ACC006&x=0&y=0

About Piribo.
Piribo is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,500 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.